Self-improving dystrophic epidermolysis bullosa: First report of clinical, molecular, and genetic characterization of five patients from Southeast Asia

Am J Med Genet A. 2021 Feb;185(2):625-630. doi: 10.1002/ajmg.a.61975. Epub 2020 Nov 30.

Abstract

Self-improving dystrophic epidermolysis bullosa is a rare subtype of dystrophic epidermolysis bullosa (DEB) characterized by significant improvement in skin fragility within the first few years of life. Genetic inheritance has previously been reported as autosomal dominant or recessive with both forms harboring mutations in COL7A1. To date, there have been no reports of this rare clinical entity from various Southeast Asian ethnicities. Here, we describe the clinical and molecular features of five patients from the Southeast Asia region who presented with predominantly acral-distributed blisters and erosions in the first few days of life. Blistering resolved over several months, without appearance of new blisters. By immunofluorescence, intraepidermal retention of Type VII collagen was observed in all patient skin biopsies when investigated with antibody staining. Genetic analysis of four patients revealed pathogenic variants in COL7A1 which have not been previously reported. The clinical diagnosis in these rare patients is confirmed with molecular histology and genetic characterization.

Keywords: Epidermolysis bullosa dystrophica; collagen Type VII genetics; collagen Type VII metabolism; fluorescent antibody technique.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asia, Southeastern / epidemiology
  • Biopsy
  • Child, Preschool
  • Collagen Type VII / genetics*
  • Epidermolysis Bullosa Dystrophica / diagnosis
  • Epidermolysis Bullosa Dystrophica / genetics*
  • Epidermolysis Bullosa Dystrophica / physiopathology
  • Epidermolysis Bullosa Dystrophica / therapy
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Skin Abnormalities / diagnosis
  • Skin Abnormalities / genetics*
  • Skin Abnormalities / physiopathology
  • Skin Abnormalities / therapy

Substances

  • COL7A1 protein, human
  • Collagen Type VII